U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6102161021Bioequivalence Study of Cephalexin Suspension 250CompletedNo Results AvailableInfections, Respiratory TractDrug: Cephalexin 125 mg/5ml|Drug: Cephalexin 250mg/5mlhttps://ClinicalTrials.gov/show/NCT01767571
6102261022PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)CompletedNo Results AvailableAtrial FibrillationOther: Ablation / MRIhttps://ClinicalTrials.gov/show/NCT01767558
6102361023Dexamethasone-implant for the Treatment of RVOCompletedNo Results AvailableMacular Edema Caused by Retinal Vein OcclusionDrug: Dexamethasone implant|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01767545
6102461024Bioequivalence Study of Cephalexin Suspension 125CompletedNo Results AvailableInfections, Respiratory TractDrug: Cephalexin 125 mg/5ml|Drug: Cephalexin 125 mg/5mlhttps://ClinicalTrials.gov/show/NCT01767532
6102561025A Study Evaluating the Efficacy and Safety of Botulinum Toxin Type A and Solifenacin in Patients With Overactive Bladder and Urinary IncontinenceCompletedNo Results AvailableOveractive Bladder|Urinary IncontinenceBiological: botulinum toxin type A|Drug: solifenacin|Drug: placebo (normal saline)|Drug: solifenacin placebohttps://ClinicalTrials.gov/show/NCT01767519
6102661026A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE TrialActive, not recruitingNo Results AvailableTrachomaOther: Surveillance and treatment with azithromycin of newcomer and traveler familieshttps://ClinicalTrials.gov/show/NCT01767506
6102761027Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS PatientsRecruitingNo Results AvailableMultiple SclerosisDrug: [18F]Florbetapir and PET imaginghttps://ClinicalTrials.gov/show/NCT01767493
6102861028Effects of Intensive Robot-assisted Therapy in Patients With Subacute StrokeCompletedNo Results AvailableStrokeDevice: RT|Behavioral: Conventional rehabilitation (CR)https://ClinicalTrials.gov/show/NCT01767480
6102961029Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersRecruitingNo Results AvailableHerpes ZosterBiological: Herpes zoster vaccine (GSK 1437173A)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01767467
6103061030Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable MelanomaActive, not recruitingNo Results AvailableSolid TumoursDrug: Dabrafenib|Drug: Trametinib|Drug: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01767454
6103161031Bariatric Surgeries and Glucose Homeostasis During a Mixed Meal TestRecruitingNo Results AvailableObesityProcedure: Roux-en-Y-gastric bypass|Procedure: laparoscopic adjustable gastric banding|Procedure: laparoscopic sleeve gastrectomy|Other: diet treatmenthttps://ClinicalTrials.gov/show/NCT01767441
6103261032Pharmacokinetic Study to Compare Two Formulations of ParacetamolCompletedNo Results AvailableFever|Headache Disorders|PainDrug: Paracetamolhttps://ClinicalTrials.gov/show/NCT01767428
6103361033Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic InjectionRecruitingNo Results AvailableBrain Tumors With Ill-defined MarginsDrug: Indigo carminehttps://ClinicalTrials.gov/show/NCT01767415
6103461034Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy AdultsCompletedNo Results AvailablePneumococcal DiseaseBiological: PhtD vaccine with/without adjuvant|Biological: Pneumovax 23TM|Biological: NaClhttps://ClinicalTrials.gov/show/NCT01767402
6103561035Glucagon-like Peptide (GLP) Utilization and SafetyCompletedNo Results AvailableDiabetes Mellitus, Type 2Other: The GLP-1 receptor agonist users|Other: DPP-4 inhibitor users|Other: Other ADA usershttps://ClinicalTrials.gov/show/NCT01767389
6103661036Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of AgeCompletedNo Results AvailableInfections, MeningococcalBiological: Meningococcal vaccine GSK134612|Biological: Boostrix®https://ClinicalTrials.gov/show/NCT01767376
6103761037WEUSKOP5723: Prostate Cancer StudyActive, not recruitingNo Results AvailableProstatic HyperplasiaOther: 5-alpha reductase inhibitors|Other: Alpha-blockershttps://ClinicalTrials.gov/show/NCT01767363
6103861038Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ TransplantationRecruitingNo Results AvailableTransplantation InfectionProcedure: Blood withdrawal for DNAhttps://ClinicalTrials.gov/show/NCT01767350
6103961039Intracutaneous Delivery of Varied Dose Volumes of SalineCompletedNo Results AvailableIntracutaneous Drug DeliveryDevice: FLUGEN 101.2 microneedle-based delivery devicehttps://ClinicalTrials.gov/show/NCT01767337
6104061040Site Selection for Intracutaneous Saline DeliveryCompletedNo Results AvailableIntracutaneous Drug DeliveryDevice: FLUGEN 101.2 microneedle-based delivery devicehttps://ClinicalTrials.gov/show/NCT01767324
6104161041A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's DiseaseDrug: BAN2401 2.5 mg/kg|Drug: BAN2401 5.0 mg/kg|Drug: BAN2401 10 mg/kg|Drug: BAN2401 5.0 mg/kg|Drug: BAN2401 10 mg/kghttps://ClinicalTrials.gov/show/NCT01767311
6104261042Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)CompletedNo Results AvailableHealthy Normotensive ParticipantsDrug: Valsartan/Hydrochlorothiazide|Drug: Valsartan|Drug: Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT01767298
6104361043Immediate vs. Delayed Postpartum Etonogestrel ImplantCompletedNo Results AvailableContinuation Rate of Contraceptive ImplantDrug: Etonogestrel implanthttps://ClinicalTrials.gov/show/NCT01767285
6104461044Dose Proportionality of Fexofenadine in Healthy Human Egyptian VolunteersCompletedNo Results AvailableHealthyDrug: fexofenadinehttps://ClinicalTrials.gov/show/NCT01767272
6104561045Pharmacokinetic Interactions of Valsartan and HydrochlorothiazideCompletedNo Results AvailableHealthy Normotensive ParticipantsDrug: Valsartan/Hydrochlorothiazide|Drug: Valsartan|Drug: Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT01767259
6104661046The Evaluation of a Novel Treatment Algorithm for Patients With Patellofemoral SyndromeCompletedNo Results AvailablePatellofemoral SyndromeOther: PFS Algorithm treatment|Other: Multimodal treatmenthttps://ClinicalTrials.gov/show/NCT01767246
6104761047Prophylactic Pancreatic Duct Stenting in Acute Necrotizing PancreatitisRecruitingNo Results AvailableAcute Necrotizing PancreatitisProcedure: ERCP and pancreatic stentinghttps://ClinicalTrials.gov/show/NCT01767233
6104861048Endo- and Epicardial vs. Endocardial Ablation of Ventricular Tachycardia in Patients With Cardiac DiseaseRecruitingNo Results AvailableVentricular TachycardiaProcedure: Strategy 1 - endocardial ablation|Procedure: Strategy 2 - endocardial and epicardial ablationhttps://ClinicalTrials.gov/show/NCT01767220
6104961049Mental Health and Cognitive Dysfunction: A Multicenter Study at Pediatric Rehabilitation Clinics in North NorwayRecruitingNo Results AvailablePsychological Disorders|Mental DisordersOther: screening for psychological disorders|Behavioral: screening for psychological disordershttps://ClinicalTrials.gov/show/NCT01767207
6105061050Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed NeuroblastomaSuspendedNo Results AvailableGanglioneuroblastoma|Recurrent NeuroblastomaBiological: Dinutuximab|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Biological: Sargramostim|Drug: Temozolomide|Drug: Temsirolimushttps://ClinicalTrials.gov/show/NCT01767194

* Görseller ve İçerik tekif hakkına sahip olabilir